Hino, Japan

Ken-ichiro Kataoka

This inventor holds 3 USPTO granted patents. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken-ichiro Kataoka. Retrieved from https://idiyas.com/inventor/ken-ichiro-kataoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 15.0

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:

goldMedal3 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ken-ichiro Kataoka

Introduction

Ken-ichiro Kataoka, a distinguished inventor based in Hino, Japan, has made significant contributions to the field of pharmaceuticals through his inventive prowess. With a remarkable portfolio of three patents, he is well-regarded for his innovations in drug development.

Latest Patents

Among his notable advancements, Kataoka's recent patents focus on cyclic amine derivatives and their therapeutic applications. These compounds have the potential to influence various medical treatments, showcasing his commitment to enhancing healthcare through innovative solutions.

Career Highlights

Kataoka's career is marked by his dedication to research and development in the pharmaceutical industry. His innovative efforts have led to multiple patent applications, securing his position as a key contributor to drug discovery. His work reflects a blend of scientific expertise and inventive spirit.

Collaborations

Throughout his career, Ken-ichiro has collaborated with talented individuals, including colleagues Tatsuki Shiota and Minoru Imai. These partnerships have fostered an environment of creativity and innovation, enabling the successful development of cutting-edge pharmaceutical compounds.

Conclusion

In conclusion, Ken-ichiro Kataoka stands out as a prominent inventor, continuously pushing the boundaries of drug innovation. His dedication to research and collaboration has not only resulted in valuable patents but has also had a lasting impact on the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…